Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Genix Pharmaceuticals (TSE:GENX)
TSXV:GENX
Holding TSE:GENX?
Track your performance easily
GENX Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.02 - C$0.10
Previous CloseC$0.05
Volume2.43K
Average Volume (3M)10.37K
Market Cap
C$2.67M
Enterprise ValueC$3.39M
Total Cash (Recent Filing)C$10.23K
Total Debt (Recent Filing)C$739.34K
Price to Earnings (P/E)―
Beta-0.20
Next Earnings
Mar 04, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding59,224,131
10 Day Avg. Volume988
30 Day Avg. Volume10,366
Standard Deviation0.28
R-Squared0.00506
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)-2.00
Price to Sales (P/S)743.46
Price to Cash Flow (P/CF)-16.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Genix Pharmaceuticals News
PremiumCompany Announcements
Genix Pharmaceuticals Enhances Warrant TermsOptions Prices
Currently, No data available
---
Ownership Overview
GENX FAQ
What was Genix Pharmaceuticals’s price range in the past 12 months?
Genix Pharmaceuticals lowest stock price was C$0.01 and its highest was C$0.10 in the past 12 months.
What is Genix Pharmaceuticals’s market cap?
Currently, no data Available
When is Genix Pharmaceuticals’s upcoming earnings report date?
Genix Pharmaceuticals’s upcoming earnings report date is Mar 04, 2025 which is in 97 days.
How were Genix Pharmaceuticals’s earnings last quarter?
Genix Pharmaceuticals released its earnings results on Sep 19, 2024. The company reported -C$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.001.
Is Genix Pharmaceuticals overvalued?
According to Wall Street analysts Genix Pharmaceuticals’s price is currently Overvalued.
Does Genix Pharmaceuticals pay dividends?
Genix Pharmaceuticals does not currently pay dividends.
What is Genix Pharmaceuticals’s EPS estimate?
Genix Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Genix Pharmaceuticals have?
Genix Pharmaceuticals has 59,224,133 shares outstanding.
What happened to Genix Pharmaceuticals’s price movement after its last earnings report?
Genix Pharmaceuticals reported an EPS of -C$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Genix Pharmaceuticals?
Currently, no hedge funds are holding shares in TSE:GENX
---
Genix Pharmaceuticals Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
4.65%
12-Months-Change
Fundamentals
Return on Equity
-661.13%
Trailing 12-Months
Asset Growth
-93.94%
Trailing 12-Months
Company Description
Genix Pharmaceuticals
Genix Pharmaceuticals Corp is a Canadian life sciences company engaged in the research, development, manufacturing and marketing of high growth, high margin, novel and proprietary, evidence-based, pharmaceuticals, over-the-counter products, nutraceuticals and healthcare products, as well as generic medicines.
---
Technical Analysis
---